Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)
Clinical trial NCT00882102 · COMPLETED
Trial details
- NCT number
- NCT00882102
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2012-08-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.